Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index; 7 of the 20 sources its claims cite were checked for support.

Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes

Open access

Abstract

OBJECTIVE: To assess the effectiveness of structured blood glucose testing in poorly controlled, noninsulin-treated type 2 diabetes. RESEARCH DESIGN AND METHODS: This 12-month, prospective, cluster-randomized, multicenter study recruited 483 poorly controlled (A1C ≥7.5%), insulin-naïve type 2 diabetic subjects from 34 primary care practices in the U.S. Practices were randomized to an active control group (ACG) with enhanced usual care or a structured testing group (STG) with enhanced usual care and at least quarterly use of structured self-monitoring of blood glucose (SMBG). STG patients and physicians were trained to use a paper tool to collect/interpret 7-point glucose profiles over 3 consecutive days. The primary end point was A1C level measured at 12 months. RESULTS: The 12-month intent-to-treat analysis (ACG, n = 227; STG, n = 256) showed significantly greater reductions in mean (SE) A1C in the STG compared with the ACG: −1.2% (0.09) vs. −0.9% (0.10); Δ = −0.3%; P = 0.04. Per protocol analysis (ACG, n = 161; STG, n = 130) showed even greater mean (SE) A1C reductions in the STG compared with the ACG: −1.3% (0.11) vs. −0.8% (0.11); Δ = −0.5%; P < 0.003. Significantly more STG patients received a treatment change recommendation at the month 1 visit compared with ACG patients, regardless of the patient’s initial baseline A1C level: 179 (75.5%) vs. 61 (28.0%); <0.0001. Both STG and ACG patients displayed significant (P < 0.0001) improvements in general well-being (GWB). CONCLUSIONS: Appropriate use of structured SMBG significantly improves glycemic control and facilitates more timely/aggressive treatment changes in noninsulin-treated type 2 diabetes without decreasing GWB.

Overview

CoChat Summary

TL;DR

In poorly controlled, insulin-naïve type 2 diabetes, structured self-monitoring of blood glucose (SMBG) plus enhanced usual care reduced A1C significantly more than enhanced usual care alone over 12 months. It also produced more timely treatment changes without decreasing general well-being.

Key findings

  • In the intent-to-treat analysis (ACG n = 227; STG n = 256), mean (SE) A1C reductions were −1.2% (0.09) for STG vs. −0.9% (0.10) for ACG; Δ = −0.3%; P = 0.04. Per-protocol reductions were −1.3% (0.11) vs. −0.8% (0.11); Δ = −0.5%; P < 0.003.
  • Significantly more STG patients received a treatment change recommendation at month 1: 179 (75.5%) vs. 61 (28.0%); P < 0.0001. Mean (SD) scheduled visits with a treatment change recommendation were 2.7 (1.5) vs. 1.1 (1.0); P < 0.0001. More STG patients started intermediate- or long-acting insulin: 42 vs. 23; P = 0.046.
  • STG subjects showed reduced preprandial-to-postprandial glucose excursions from month 1 to month 12: breakfast 44 to 35 mg/dL (P < 0.005), lunch 25 to 17 mg/dL (P < 0.03), supper 34 to 26 mg/dL (P < 0.05). Mean amplitude of glucose excursions fell from 38.5 (0.9) to 34.3 (1.0) mg/dL (P = 0.0003).
  • General well-being improved in both groups (ACG P < 0.007; STG P < 0.0001), with no significant between-group difference over time; per-protocol adherent STG subjects had greater improvement than adherent ACG subjects (P < 0.04).

Methods

  • 12-month prospective, cluster-randomized, multicenter study in 34 U.S. primary care practices randomized to active control (ACG, n = 13 practices) or structured testing (STG, n = 21 practices); 483 poorly controlled (A1C ≥7.5%), insulin-naïve type 2 diabetes patients were included in the intent-to-treat cohort (ACG n = 227; STG n = 256).
  • STG patients and physicians used the Accu-Chek 360° View tool to collect/interpret 7-point glucose profiles over 3 consecutive days before scheduled visits; ACG received enhanced usual care only. Primary endpoint was A1C at 12 months.
  • Linear mixed models compared groups over time, controlling for baseline A1C, age, gender, and race as fixed effects and practice site and subject as random effects; intent-to-treat and per-protocol analyses were performed.

Limitations

  • Stated: no third study arm assessed the effect of increased attention in both groups; the study could not determine whether treatment changes were clinically appropriate, because it measured number rather than type of change; it could not determine how many recommended changes actually occurred; and STG had greater attrition than ACG (not statistically significant), possibly reflecting intervention burden and biasing findings.
  • Evident from the text: the ACG received enhanced usual care, free meters/strips, and more frequent visits, so between-group differences may be conservative; per-protocol results depend on adherence definitions and exclusion of nonadherent STG patients, which may limit generalizability.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.2337/dc10-1732

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Consort diagram.
Figure 1 Consort diagram.CC BY-NC-ND · PubMed Central
Figure 2 A: ITT analysis: mean (± SE) A1C over 12 months (M) in patients with noninsulin-treated type 2 diabetes according to randomization group.B: PP analysis: mean (± SE) A1C over 12 months (M) in patients with noninsulin-treated type 2 diabetes, comparing ACG patients, adherent STG (STG/a) patients, and nonadherent STG (STG/na) patients.
Figure 2 A: ITT analysis: mean (± SE) A1C over 12 months (M) in patients with noninsulin-treated type 2 diabetes according to randomization group.B: PP analysis: mean (± SE) A1C over 12 months (M) in patients with noninsulin-treated type 2 diabetes, comparing ACG patients, adherent STG (STG/a) patients, and nonadherent STG (STG/na) patients.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

4 Valid · 1 Not valid · 4 Not checked · 51 Own results and interpretations

25 more claims

Create a free account to see all 60 claims and to verify the 2 references still open.

See all claims — free account
  • Probably not a substantial claim. 21
  • It may state two separate claims as one. 11

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 26 references

Cited by

See all 429

Metadata

Authors
Polonsky, W. H., Fisher, L., Schikman, C. H., Hinnen, D. A., Parkin, C. G., Jelsovsky, Z., Petersen, B., Schweitzer, M., & Wagner, R. S.
Affiliations
  • University of California San Diego (US)
  • University of California, San Francisco (US)
  • Endeavor Health (US)
  • Mid America Diabetes Associates, Wichita, Kansas
  • Health Management Resources, Carmel, Indiana
  • Biostat International, Tampa, Florida
  • Roche Diagnostics, Indianapolis, Indiana
Corresponding author
Parkin, Christopher G.
Venue
Diabetes Care
Published
2011-01-20
Volume
34
Issue
2
Pages
262-267
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2102487069
Cited by
429
References
26
Citations by year
2026: 11 · 2025: 11 · 2024: 18 · 2023: 15 · 2022: 20 · 2021: 27 · 2020: 21 · 2019: 26 · 2018: 28 · 2017: 25 · 2016: 47 · 2015: 37 · 2014: 31 · 2013: 44 · 2012: 43
FWCI
37.46
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
type 2 diabetes, glycemic control, HbA1c, insulin-naive patients, glycemic variability, treatment intensification, general well-being, primary care
MeSH terms
Adult, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Male, Middle Aged, Patient Education as Topic, Patient Participation, Primary Health Care, Prospective Studies, Blood Glucose Self-Monitoring

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes. https://app.cochat.ai/papers/10.2337/dc10-1732
The paper
Polonsky, W. H., Fisher, L., Schikman, C. H., Hinnen, D. A., Parkin, C. G., Jelsovsky, Z., Petersen, B., Schweitzer, M., & Wagner, R. S. (2011). Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes. Diabetes Care. https://doi.org/10.2337/dc10-1732

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.